Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2

Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2

In the past two decades, pandemics of several fatal coronaviruses have posed enormous challenges for public health, including SARS-CoV (2003), MERS-CoV (2012), and SARS-CoV-2 (2019). Among these, SARS-CoV-2 continues to ravage the world today and has lead to millions of deaths and incalculable econo...

Full description

Bibliographic Details
Main Authors:	Wei Chen, Zhihao Wang, Yawen Wang, Yiping Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-08-01
Series:	Frontiers in Pharmacology
Subjects:	coronavirus COVID-19 SARS-CoV-2 antiviral agents natural bioactive molecules therapeutic targets
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.702472/full

Similar Items

Coronavirus (SARS-CoV-2): Preventions, keys to diagnosis and treatment of SARS-CoV-2
by: Kuldeep Singh Patel, et al.
Published: (2020-03-01)

Algae-Derived Bioactive Molecules for the Potential Treatment of SARS-CoV-2
by: Md. Asraful Alam, et al.
Published: (2021-04-01)

Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2
by: Jie Hu, et al.
Published: (2020-12-01)

Bioactive Molecules of Tea as Potential Inhibitors for RNA-Dependent RNA Polymerase of SARS-CoV-2
by: Vijay Kumar Bhardwaj, et al.
Published: (2021-05-01)

Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike
by: João Trigueiro-Louro, et al.
Published: (2020-01-01)

Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus
by: Irina Leneva, et al.
Published: (2021-08-01)

Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
by: Igor de Andrade Santos, et al.
Published: (2020-08-01)

Baicalein and Baicalin Inhibit SARS-CoV-2 RNA-Dependent-RNA Polymerase
by: Keivan Zandi, et al.
Published: (2021-04-01)

Natural Products as Potential Leads Against Coronaviruses: Could They be Encouraging Structural Models Against SARS-CoV-2?
by: Ilkay Erdogan Orhan, et al.
Published: (2020-06-01)

Valinomycin as a potential antiviral agent against coronaviruses: A review
by: Dong Zhang, et al.
Published: (2020-10-01)

Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets
by: Su-Jin Park, et al.
Published: (2020-05-01)

Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2
by: Sreejith Rajasekharan, et al.
Published: (2021-04-01)

The virus that shook the world: questions and answers about SARS-CoV-2 and COVID-19
by: Radostina Alexandrova, et al.
Published: (2021-01-01)

Compelling Evidence for the Activity of Antiviral Peptides against SARS-CoV-2
by: Miray Tonk, et al.
Published: (2021-05-01)

Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside
by: Sijia Tao, et al.
Published: (2021-01-01)

Diabetes and coronavirus infections (SARS-CoV, MERS-CoV, and SARS-CoV-2)
by: Azadeh Haghi Navand, et al.
Published: (2020-01-01)

Therapeutic Strategies Against COVID-19 and Structural Characterization of SARS-CoV-2: A Review
by: Gi Uk Jeong, et al.
Published: (2020-07-01)

Convalescent plasma as a therapeutic agent for SARS-CoV, MERS-CoV and SARS-CoV-2: A scoping review
by: Abeba Haile Mariamenatu, et al.
Published: (2021-01-01)

Silver-Based Nanomaterials as Therapeutic Agents Against Coronaviruses: A Review
by: Das C, et al.
Published: (2020-11-01)

A Fungal Defensin Targets the SARS−CoV−2 Spike Receptor−Binding Domain
by: Bin Gao, et al.
Published: (2021-07-01)

The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model
by: Rana Abdelnabi, et al.
Published: (2021-10-01)

The Antiviral, Anti-Inflammatory Effects of Natural Medicinal Herbs and Mushrooms and SARS-CoV-2 Infection
by: Fanila Shahzad, et al.
Published: (2020-08-01)

Important Roles of Oligo- and Polysaccharides against SARS-CoV-2: Recent Advances
by: Siavash Iravani, et al.
Published: (2021-04-01)

Phycobilins as Potent Food Bioactive Broad-Spectrum Inhibitors Against Proteases of SARS-CoV-2 and Other Coronaviruses: A Preliminary Study
by: Brahmaiah Pendyala, et al.
Published: (2021-06-01)

GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection
by: Shin-ichiro Hattori, et al.
Published: (2020-08-01)

New perspective towards therapeutic regimen against SARS-CoV-2 infection
by: Vartika Srivastava, et al.
Published: (2021-07-01)

Interferon-β: treatment option against COVID-19
by: Faiz Ul haq, et al.
Published: (2020-07-01)

An overview of SARS-COV-2: Virology, Epidemiology, Pathogenesis and Treatment
by: Ramesh Bhandari, et al.
Published: (2020-06-01)

REVISIÓN DE LA ACTIVIDAD ANTIVIRAL IN VITRO DE PLANTAS SUDAMERICANAS A PROPÓSITO DEL CORONAVIRUS SARS-CoV-2
by: Omar Vacas C., et al.
Published: (2020-12-01)

A Carbohydrate-Binding Protein from the Edible Lablab Beans Effectively Blocks the Infections of Influenza Viruses and SARS-CoV-2
by: Yo-Min Liu, et al.
Published: (2020-08-01)

Host Cell and SARS-CoV-2-Associated Molecular Structures and Factors as Potential Therapeutic Targets
by: Jitendra Kumar Chaudhary, et al.
Published: (2021-09-01)

Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective
by: Mona Seifert, et al.
Published: (2021-10-01)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
by: Jung Eun Huh, et al.
Published: (2021-04-01)

Antiviral Effect of Budesonide against SARS-CoV-2
by: Natalie Heinen, et al.
Published: (2021-07-01)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
by: Yun-yu Zhang, et al.
Published: (2020-08-01)

Identifying Structural Features of Nucleotide Analogues to Overcome SARS-CoV-2 Exonuclease Activity
by: Ju, J., et al.
Published: (2022)

Could the Inhibition of Endo-Lysosomal Two-Pore Channels (TPCs) by the Natural Flavonoid Naringenin Represent an Option to Fight SARS-CoV-2 Infection?
by: Antonio Filippini, et al.
Published: (2020-04-01)

Prediction and Analysis of SARS-CoV-2-Targeting MicroRNA in Human Lung Epithelium
by: Jonathan Tak-Sum Chow, et al.
Published: (2020-08-01)

Comprehensive virtual screening of 4.8 k flavonoids reveals novel insights into allosteric inhibition of SARS-CoV-2 M<sup>PRO</sup>
by: Jiménez-Avalos, Gabriel, et al.
Published: (2021)

The study of antiviral drugs targeting SARS-CoV-2 nucleocapsid and spike proteins through large-scale compound repurposing
by: Xuqiao Hu, et al.
Published: (2021-03-01)